Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pfizer Reshapes Portfolio With Metsera Deal Novavax Pact And R&D Push - Simply Wall St News
Novavax (NASDAQ:NVAX) Downgraded to "Sell" Rating by Wall Street Zen - Markets Daily
Pfizer Reshapes Portfolio With New Partnerships Oncology Push And Pricing Shifts
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Analysts
Assessing Novavax (NVAX) Valuation After Pfizer Licensing Deal For Matrix M Adjuvant
Novavax (NASDAQ:NVAX) Stock Rating Upgraded by Wall Street Zen - Daily Political
Strs Ohio Buys 134,516 Shares of Pfizer Inc. $PFE - Markets Daily
Will Licensing Novavax's Matrix-M Adjuvant Reshape Pfizer's (PFE) Vaccine Platform Strategy?
Reassessing Novavax (NVAX) After Recent Share Price Rebound And Valuation Signals
Pfizer Inc. $PFE Position Raised by Strs Ohio - Stock Observer
The Bull Case For Pfizer (PFE) Could Change Following Novavax Matrix-M Adjuvant Licensing Deal - Learn Why
Why Are Novavax (NVAX) Shares Soaring Today
Traders Buy Large Volume of Call Options on Novavax (NASDAQ:NVAX)
Stock Traders Buy High Volume of Novavax Call Options (NASDAQ:NVAX) - Daily Political
Novavax signs licensing agreement with Pfizer for vaccine development
Assessing Novavax (NVAX) Valuation After Pfizer Matrix M Licensing Deal
Novavax (NASDAQ:NVAX) Stock Price Up 8% - Still a Buy?
Novavax's (NVAX) Buy Rating Reiterated at BTIG Research
Pfizer is paying $30 million to…
Novavax Licenses Matrix-M Adjuvant To Pfizer For Upfront Payment Of $30 Mln
Is Novavax's (NVAX) Partner-Led Shift With Sanofi Quietly Rewriting Its Risk-Reward Equation? - Simply Wall St News
Novavax (NASDAQ:NVAX) Trading 5.5% Higher - Here's Why - Markets Daily
Novavax (NASDAQ:NVAX) Trading Down 6.1% - What's Next?
Novavax (NASDAQ:NVAX) Trading Down 6.1% - Should You Sell? - Daily Political
Novavax (NASDAQ:NVAX) Trading 5.5% Higher - Here's What Happened
Novavax (NASDAQ:NVAX) Stock Price Up 5.5% - Still a Buy? - Stock Observer
Why Novavax (NVAX) Is Up 9.2% After Singapore Backs Nuvaxovid And Analysts Hike Estimates
Is Novavax (NVAX) A Potential Opportunity After Recent Vaccine Market Volatility?
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Analysts Conflicted on These Healthcare Names: Stereotaxis (STXS) and Novavax (NVAX) | Markets Insider
Is Novavax (NVAX) Mispriced After Recent Share Rebound And DCF Upside Projection
Novavax Sees Unusually Large Options Volume (NASDAQ:NVAX)
Novavax Target of Unusually Large Options Trading (NASDAQ:NVAX) - Stock Observer
Latest news
Show moreZelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks
Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets
Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty
